4//SEC Filing
GOOD JENNIFER L 4
Accession 0001104659-24-098941
CIK 0001649904other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:30 PM ET
Size
19.9 KB
Accession
0001104659-24-098941
Insider Transaction Report
Form 4
GOOD JENNIFER L
Director
Transactions
- Exercise/Conversion
Common Stock
2024-09-09$21.37/sh+4,305$91,998→ 20,205 total - Exercise/Conversion
Common Stock
2024-09-09$4.15/sh+18,300$75,945→ 40,241 total - Exercise/Conversion
Stock Option (right to buy)
2024-09-09−12,900→ 15,000 totalExercise: $22.93Exp: 2029-06-18→ Common Stock (12,900 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-09-09−4,305→ 9,250 totalExercise: $21.37Exp: 2030-06-16→ Common Stock (4,305 underlying) - Exercise/Conversion
Common Stock
2024-09-09$22.93/sh+12,900$295,797→ 15,900 total - Exercise/Conversion
Common Stock
2024-09-09$18.99/sh+1,736$32,967→ 21,941 total - Sale
Common Stock
2024-09-09$50.45/sh−37,241$1,878,700→ 3,000 total - Exercise/Conversion
Stock Option (right to buy)
2024-09-09−18,300→ 0 totalExercise: $4.15Exp: 2032-06-07→ Common Stock (18,300 underlying) - Exercise/Conversion
Stock Option (right to buy)
2024-09-09−1,736→ 7,501 totalExercise: $18.99Exp: 2031-06-08→ Common Stock (1,736 underlying)
Footnotes (3)
- [F1]The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted on May 22, 2024.
- [F2]The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $50.00 to $50.99. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- [F3]The option is fully vested and exercisable.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001229245
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 4:30 PM ET
- Size
- 19.9 KB